View in EDS

Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.

Saved in:
Bibliographic Details
Title: Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
Authors: Kankasa C; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., Mennecier A; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France., Sakana BLD; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso., Molès JP; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France., Mwiya M; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., Chunda-Liyoka C; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., D'Ottavi M; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France., Tassembedo S; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso., Wilfred-Tonga MM; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., Fao P; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso., Rutagwera D; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., Matoka B; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia., Kania D; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso., Taofiki OA; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso., Tylleskär T; Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway., Van de Perre P; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France., Nagot N; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France. Electronic address: n-nagot@chu-montpellier.fr.
Corporate Authors: PROMISE-EPI Trial Group
Source: Lancet (London, England) [Lancet] 2024 Apr 06; Vol. 403 (10434), pp. 1362-1371. Date of Electronic Publication: 2024 Mar 11.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38484756
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kankasa+C%22">Kankasa C</searchLink>; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.<br /><searchLink fieldCode="AU" term="%22Mennecier+A%22">Mennecier A</searchLink>; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Sakana+BLD%22">Sakana BLD</searchLink>; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Molès+JP%22">Molès JP</searchLink>; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Mwiya+M%22">Mwiya M</searchLink>; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.<br /><searchLink fieldCode="AU" term="%22Chunda-Liyoka+C%22">Chunda-Liyoka C</searchLink>; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.<br /><searchLink fieldCode="AU" term="%22D'Ottavi+M%22">D'Ottavi M</searchLink>; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Tassembedo+S%22">Tassembedo S</searchLink>; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Wilfred-Tonga+MM%22">Wilfred-Tonga MM</searchLink>; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.<br /><searchLink fieldCode="AU" term="%22Fao+P%22">Fao P</searchLink>; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Rutagwera+D%22">Rutagwera D</searchLink>; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.<br /><searchLink fieldCode="AU" term="%22Matoka+B%22">Matoka B</searchLink>; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.<br /><searchLink fieldCode="AU" term="%22Kania+D%22">Kania D</searchLink>; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Taofiki+OA%22">Taofiki OA</searchLink>; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Tylleskär+T%22">Tylleskär T</searchLink>; Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Van+de+Perre+P%22">Van de Perre P</searchLink>; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Nagot+N%22">Nagot N</searchLink>; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS, CHU Montpellier, Montpellier, France. Electronic address: n-nagot@chu-montpellier.fr.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PROMISE-EPI+Trial+Group%22">PROMISE-EPI Trial Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2024 Apr 06; Vol. 403 (10434), pp. 1362-1371. <i>Date of Electronic Publication: </i>2024 Mar 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38484756
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(23)02464-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1362
    Titles:
      – TitleFull: Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kankasa C
      – PersonEntity:
          Name:
            NameFull: Mennecier A
      – PersonEntity:
          Name:
            NameFull: Sakana BLD
      – PersonEntity:
          Name:
            NameFull: Molès JP
      – PersonEntity:
          Name:
            NameFull: Mwiya M
      – PersonEntity:
          Name:
            NameFull: Chunda-Liyoka C
      – PersonEntity:
          Name:
            NameFull: D'Ottavi M
      – PersonEntity:
          Name:
            NameFull: Tassembedo S
      – PersonEntity:
          Name:
            NameFull: Wilfred-Tonga MM
      – PersonEntity:
          Name:
            NameFull: Fao P
      – PersonEntity:
          Name:
            NameFull: Rutagwera D
      – PersonEntity:
          Name:
            NameFull: Matoka B
      – PersonEntity:
          Name:
            NameFull: Kania D
      – PersonEntity:
          Name:
            NameFull: Taofiki OA
      – PersonEntity:
          Name:
            NameFull: Tylleskär T
      – PersonEntity:
          Name:
            NameFull: Van de Perre P
      – PersonEntity:
          Name:
            NameFull: Nagot N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 04
              Text: 2024 Apr 06
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1474-547X
          Numbering:
            – Type: volume
              Value: 403
            – Type: issue
              Value: 10434
          Titles:
            – TitleFull: Lancet (London, England)
              Type: main
ResultId 1